View this email in a browser | |||||||||
Conventional treatment for youth with obesity comprehensively addresses nutrition and physical activity, with the goal of achieving a negative energy balance and promoting weight loss. With the growing epidemic of obesity in youth, there is increasing interest in using both prescriptive nutrition strategies and medication to optimize and promote improved health outcomes both in the short term and sustained over time. Many prescriptive nutrition strategies and medications have been used successfully in adults but less is known about their effectiveness and safety in youth.
On Wednesday, August 24, 2022, from 2-3 p.m. ET, join Michael Goran, PhD, and Alaina Vidmar, MD, for a webinar that will discuss the various types of prescriptive nutrition strategies and pharmacotherapies used in the treatment of children and teenagers living in larger bodies. Dr. Goran will dive into recent research on the use of prescriptive nutrition strategies in youth, and Dr. Vidmar will explore how weight loss medications can be used alongside lifestyle modifications to promote positive health outcomes. Participants will leave the session with new knowledge about how to counsel clients on the use of prescriptive nutrition strategies and gained education around the use of weight loss medications in youth. Learning Objectives
|
|||||||||
|
|||||||||
|
|||||||||
About Our Presenters Dr. Goran is a native of Glasgow, Scotland, and received his Ph.D. from the University of Manchester, UK, prior to his postdoctoral training in the US. He previously served on the faculty of medicine at the University of Vermont, and the Department of Nutrition Sciences at the University of Alabama at Birmingham prior to joining USC in 1999. Dr Goran’s research has focused on the causes and consequences of childhood obesity for 30 years and has been continuously funded by NIH and other foundations during which he has raised over $75m in funding. He’s published over 350 peer-reviewed articles and reviews. Dr. Goran is the Editor of the “Childhood Obesity: Causes, Consequences and Intervention Approaches” published in 2017, co-editor of “Dietary Sugars and Health” published in late 2014, and currently serves as Editor-in-Chief for Pediatric Obesity. He is the author of “Sugarproof: The Hidden Dangers of Sugar That Are Putting Your Child’s Health at Risk and What You Can Do,” and he has been the recipient of numerous scientific awards for his research and teaching. Full details on Dr. Goran’s research can be found on his website, GoranLab.com. Dr. Vidmar’s lab is interested in three components of the treatment of obesity in adolescents: 1) Cognitive phenotyping: The relationships between food addiction, executive function and mood in adolescents with obesity are not well-understood. Her lab aims to categorize these cognitive phenotypes to better understand how these phenotypes impact treatment engagement and response. 2) Intervention Delivery Modalities: Her lab aims to utilize app-based interventions to deliver targeted treatment in their real life setting to determine which delivery method is most cost effective at promoting sustained behavior change and weight control. 3) Chrononutrition: Dr. Vidmar is interested in investigating how pediatric chronobiological intersects with nutrition and obesity. She is gathering data to investigate how sleep timing, eating periods and glycemic excursions overlap to impact metabolic health in adolescents across the spectrum of beta cell dysfunction. |
|||||||||
Disclosures Michael I. Goran, PhD, faculty for this event, has no relevant financial relationship(s) with ineligible companies to disclose. Alaina Vidmar, MD, faculty for this event, has no relevant financial relationship(s) with ineligible companies to disclose. None of the planners for this educational activity have no relevant financial relationship(s) with ineligible companies to disclose. An “ineligible company” includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products use by or on patients. |
|||||||||
Joint Accreditation Statement: |